天(tian)(tian)(tian)津天(tian)(tian)(tian)藥(yao)(yao)藥(yao)(yao)業(ye)(ye)股(gu)份(fen)(fen)有限公(gong)(gong)司(si)(簡(jian)稱(cheng)天(tian)(tian)(tian)藥(yao)(yao)股(gu)份(fen)(fen))成立(li)于1999年(nian)(nian)(nian)12月1日(ri)。 2001年(nian)(nian)(nian)6月18日(ri)在上(shang)海證(zheng)券交易所上(shang)市,股(gu)票(piao)代(dai)碼(ma)600488。天(tian)(tian)(tian)藥(yao)(yao)股(gu)份(fen)(fen)的前身是(shi)天(tian)(tian)(tian)津制(zhi)藥(yao)(yao)廠,始(shi)建(jian)于1939年(nian)(nian)(nian)。自20世(shi)紀50-60年(nian)(nian)(nian)代(dai),開發、研(yan)制(zhi)和(he)生(sheng)(sheng)產(chan)(chan)皮(pi)質(zhi)(zhi)激(ji)素類(lei)(lei)原(yuan)(yuan)料(liao)(liao)藥(yao)(yao),是(shi)中(zhong)國皮(pi)質(zhi)(zhi)激(ji)素類(lei)(lei)藥(yao)(yao)物的開拓者之(zhi)一(yi),國內頗具影響力(li)的皮(pi)質(zhi)(zhi)激(ji)素原(yuan)(yuan)料(liao)(liao)藥(yao)(yao)科研(yan)、生(sheng)(sheng)產(chan)(chan)和(he)出口(kou)基地(di)。2017年(nian)(nian)(nian)公(gong)(gong)司(si)完(wan)成了(le)收購天(tian)(tian)(tian)津金(jin)(jin)耀(yao)藥(yao)(yao)業(ye)(ye)有限公(gong)(gong)司(si)(簡(jian)稱(cheng)“金(jin)(jin)耀(yao)藥(yao)(yao)業(ye)(ye)”)的重組(zu)項目,實現(xian)了(le)從(cong)單一(yi)“原(yuan)(yuan)料(liao)(liao)藥(yao)(yao)”到“原(yuan)(yuan)料(liao)(liao)藥(yao)(yao)和(he)制(zhi)劑(ji)”業(ye)(ye)務優勢互(hu)補(bu)、雙(shuang)輪聯動的戰略轉型。公(gong)(gong)司(si)現(xian)有控(kong)股(gu)和(he)參股(gu)公(gong)(gong)司(si)16家,總資產(chan)(chan)43億元。天(tian)(tian)(tian)藥(yao)(yao)股(gu)份(fen)(fen)與金(jin)(jin)耀(yao)藥(yao)(yao)業(ye)(ye)均為高新(xin)技術(shu)企業(ye)(ye)。天(tian)(tian)(tian)藥(yao)(yao)股(gu)份(fen)(fen)主要生(sheng)(sheng)產(chan)(chan)皮(pi)質(zhi)(zhi)激(ji)素及氨基酸類(lei)(lei)原(yuan)(yuan)料(liao)(liao)藥(yao)(yao),常(chang)年(nian)(nian)(nian)生(sheng)(sheng)產(chan)(chan)品種包括地(di)塞米(mi)松系列(lie)、潑尼(ni)松系列(lie)、甲(jia)潑尼(ni)龍系列(lie)、倍他米(mi)松系列(lie)等6大系列(lie)30余個皮(pi)質(zhi)(zhi)激(ji)素原(yuan)(yuan)料(liao)(liao)藥(yao)(yao)品種,年(nian)(nian)(nian)產(chan)(chan)能(neng)(neng)力(li)250噸(dun)以(yi)上(shang),氨基酸原(yuan)(yuan)料(liao)(liao)藥(yao)(yao)產(chan)(chan)能(neng)(neng)2000噸(dun)。金(jin)(jin)耀(yao)藥(yao)(yao)業(ye)(ye)擁有小(xiao)(xiao)容量注射劑(ji)、軟膏(gao)(gao)劑(ji)、乳膏(gao)(gao)劑(ji)、涂膜劑(ji)、凝(ning)膠(jiao)劑(ji)、膜劑(ji)、栓(shuan)劑(ji)、硬膠(jiao)囊劑(ji)、丸劑(ji)、凍干粉針劑(ji)等14個劑(ji)型208個產(chan)(chan)品文(wen)號,其中(zhong)片(pian)(pian)劑(ji)年(nian)(nian)(nian)產(chan)(chan)能(neng)(neng)力(li)50億片(pian)(pian)以(yi)上(shang),小(xiao)(xiao)容量注射劑(ji)、膏(gao)(gao)劑(ji)和(he)膠(jiao)囊劑(ji)的年(nian)(nian)(nian)產(chan)(chan)能(neng)(neng)分(fen)別達52,400萬支(zhi)、30,000萬支(zhi)和(he)16,560萬粒(li)。
天(tian)(tian)藥(yao)股份在天(tian)(tian)津、新加(jia)坡和美國(guo)(guo)新澤西建立了(le)三家(jia)控股銷(xiao)售公司,分別負責公司在歐(ou)洲(zhou)、亞洲(zhou)和美洲(zhou)的(de)業(ye)務開拓,皮質激(ji)素原料藥(yao)有(you)60%以上出口到亞洲(zhou)、歐(ou)洲(zhou)、美洲(zhou)的(de)70多個國(guo)(guo)家(jia)和地區(qu),國(guo)(guo)內銷(xiao)售覆蓋中(zhong)國(guo)(guo)近百(bai)個城市,具有(you)較強(qiang)的(de)市場影響力和占有(you)率。金耀(yao)藥(yao)業(ye)的(de)制劑產(chan)品(pin)銷(xiao)售也是覆蓋全國(guo)(guo),產(chan)品(pin)品(pin)牌享譽國(guo)(guo)內外。收購金耀(yao)藥(yao)業(ye)后的(de)天(tian)(tian)藥(yao)股份將(jiang)進一步整合資源、優化(hua)營銷(xiao)策略(lve),強(qiang)化(hua)管(guan)理和技術創(chuang)新,不(bu)斷(duan)夯實(shi)“激(ji)素專家(jia)”定位(wei),實(shi)現企業(ye)的(de)健康持續發(fa)展。